Form 4: FMR LLC Reports Beneficial Ownership Changes in Structure Therapeutics Inc.
SEC Form 4 Filing
FMR LLC, along with related entities and Abigail P. Johnson, reports changes in beneficial ownership of Structure Therapeutics Inc. securities.
Summary
- FMR LLC filed a Form 4 detailing changes in beneficial ownership of Structure Therapeutics Inc. (GPCR) securities.
- The report indicates indirect ownership of Ordinary Shares through F-Prime Capital Partners Life Sciences Advisors Fund VI LP (45,120 shares) and F-Prime Capital Partners Life Sciences Fund VI LP (530,814 shares).
- FMR LLC, Abigail P. Johnson, and related entities may be deemed to have beneficial ownership due to their relationships and agreements.
- The filing clarifies that it is not an admission of beneficial ownership for Section 16 purposes.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Industry Context
This filing is a routine disclosure related to changes in beneficial ownership, which is common for investment firms and individuals holding significant positions in publicly traded companies. It reflects the ongoing investment activities of FMR LLC and its affiliated funds in the biotechnology sector.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the ownership structure of Structure Therapeutics Inc.
Key Dates
| Date | Description |
|---|---|
| 02/06/2025 | Date of earliest transaction reported. |
| 02/10/2025 | Date of signature for the Form 4 filing. |
Keywords
beneficial ownership, FMR LLC, Structure Therapeutics Inc., GPCR, Abigail P. Johnson, F-Prime Capital Partners, Form 4, securities, ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.